Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Y Yu

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
Urology|March 18, 2017
The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)E David Crawford, Daniel P Petrylak, Neal Shore, et al.
The Journal of Urology|August 6, 2018
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)E David Crawford, Phillip J Koo, Neal Shore, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2022
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinomaGuru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, et al.
The Lancet. Oncology|May 29, 2021
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trialThomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, et al.
Urology|June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and ComplicationsClaire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Cancer|June 1, 2019
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancerAlberto Martini, Rachel Jia, Bart S Ferket, et al.
Acta Oncologica (Stockholm, Sweden)|August 31, 2017
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) InvestigatorsJihane Boustani, Aurélie Bertaut, Matthew D Galsky, et al.
Clinical Genitourinary Cancer|November 22, 2017
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient PopulationAndrea Necchi, Gregory R Pond, Sumanta K Pal, et al.
Lancet (London, England)|April 20, 2010
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 studyHoward I Scher, Tomasz M Beer, Celestia S Higano, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
Urology|March 18, 2017
The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)E David Crawford, Daniel P Petrylak, Neal Shore, et al.
The Journal of Urology|August 6, 2018
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)E David Crawford, Phillip J Koo, Neal Shore, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2022
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinomaGuru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, et al.
The Lancet. Oncology|May 29, 2021
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trialThomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, et al.
Urology|June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and ComplicationsClaire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Cancer|June 1, 2019
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancerAlberto Martini, Rachel Jia, Bart S Ferket, et al.
Acta Oncologica (Stockholm, Sweden)|August 31, 2017
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) InvestigatorsJihane Boustani, Aurélie Bertaut, Matthew D Galsky, et al.
Clinical Genitourinary Cancer|November 22, 2017
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient PopulationAndrea Necchi, Gregory R Pond, Sumanta K Pal, et al.
Lancet (London, England)|April 20, 2010
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 studyHoward I Scher, Tomasz M Beer, Celestia S Higano, et al.
Pageof 24